These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Formulation and Evaluation of Fast-Disintegrating Sublingual Tablets of Atropine Sulfate: the Effect of Tablet Dimensions and Drug Load on Tablet Characteristics. Aodah A, Bafail RS, Rawas-Qalaji M. AAPS PharmSciTech; 2017 Jul; 18(5):1624-1633. PubMed ID: 27650282 [Abstract] [Full Text] [Related]
8. Microparticle surface layering through dry coating: impact of moisture content and process parameters on the properties of orally disintegrating tablets. Alyami H, Koner J, Dahmash EZ, Bowen J, Terry D, Mohammed AR. J Pharm Pharmacol; 2017 Jul; 69(7):807-822. PubMed ID: 27696423 [Abstract] [Full Text] [Related]
9. Application of general multilevel factorial design with formulation of fast disintegrating tablets containing croscaremellose sodium and Disintequick MCC-25. Solaiman A, Suliman AS, Shinde S, Naz S, Elkordy AA. Int J Pharm; 2016 Mar 30; 501(1-2):87-95. PubMed ID: 26827922 [Abstract] [Full Text] [Related]
10. Exploitation of Design-of-Experiment Approach for Design and Optimization of Fast-Disintegrating Tablets for Sublingual Delivery of Sildenafil Citrate with Enhanced Bioavailability Using Fluid-Bed Granulation Technique. AlAli AS, Aldawsari MF, Alalaiwe A, Almutairy BK, Al-Shdefat R, Walbi IA, Fayed MH. Pharmaceutics; 2021 Jun 12; 13(6):. PubMed ID: 34204781 [Abstract] [Full Text] [Related]
11. Utility of Microcrystalline Cellulose for Improving Drug Content Uniformity in Tablet Manufacturing Using Direct Powder Compression. Nakamura S, Tanaka C, Yuasa H, Sakamoto T. AAPS PharmSciTech; 2019 Mar 22; 20(4):151. PubMed ID: 30903317 [Abstract] [Full Text] [Related]
12. Fast relief from migraine attacks using fast-disintegrating sublingual zolmitriptan tablets. Mahmoud AA, Salah S. Drug Dev Ind Pharm; 2012 Jun 22; 38(6):762-9. PubMed ID: 22023340 [Abstract] [Full Text] [Related]
13. A microcrystalline cellulose based drug-composite formulation strategy for developing low dose drug tablets. Sun WJ, Sun CC. Int J Pharm; 2020 Jul 30; 585():119517. PubMed ID: 32526333 [Abstract] [Full Text] [Related]
14. [Application of β-cyclodextrin in the formulation of ODT tablets containing ibuprofen]. Zimmer Ł, Kasperek R, Poleszak E. Polim Med; 2014 Jul 30; 44(4):231-5. PubMed ID: 25932904 [Abstract] [Full Text] [Related]
15. Comparative Study Between Different Ready-Made Orally Disintegrating Platforms for the Formulation of Sumatriptan Succinate Sublingual Tablets. Tayel SA, El Nabarawi MA, Amin MM, AbouGhaly MH. AAPS PharmSciTech; 2017 Feb 30; 18(2):410-423. PubMed ID: 27038484 [Abstract] [Full Text] [Related]
16. Application of Co-processed Excipient as a Novel Method to Compound Orally Disintegrating Tablets. Liew KB, Hii SH, Chew YL, Ming LC, Uddin AH, Sarker ZI. Int J Pharm Compd; 2022 Feb 30; 26(3):255-263. PubMed ID: 35657749 [Abstract] [Full Text] [Related]
19. Formulation of zolmitriptan sublingual tablets prepared by direct compression with different polymers: in vitro and in vivo evaluation. Bayrak Z, Tas C, Tasdemir U, Erol H, Ozkan CK, Savaser A, Ozkan Y. Eur J Pharm Biopharm; 2011 Aug 30; 78(3):499-505. PubMed ID: 21352916 [Abstract] [Full Text] [Related]
20. A quality-by-design study for an immediate-release tablet platform: examining the relative impact of active pharmaceutical ingredient properties, processing methods, and excipient variability on drug product quality attributes. Kushner J, Langdon BA, Hicks I, Song D, Li F, Kathiria L, Kane A, Ranade G, Agarwal K. J Pharm Sci; 2014 Feb 30; 103(2):527-38. PubMed ID: 24375069 [Abstract] [Full Text] [Related] Page: [Next] [New Search]